We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Leash Bio is a biotechnology company focused on transforming drug discovery by building an incredibly rich dataset of biochemical measurements. They achieve this by screening millions of compounds against thousands of proteins, generating billions of data points. This massive dataset is specifically designed to train advanced machine learning (ML) models for more effective and efficient drug design.
Traditional drug discovery is a lengthy and expensive process. Leash Bio aims to shorten the timeline and reduce costs by providing the raw material – high-quality data – needed for AI to accelerate the process. Instead of relying solely on traditional methods, pharmaceutical companies and research institutions can leverage Leash Bio's dataset to develop more accurate predictive models and identify promising drug candidates faster.
The core value proposition of Leash Bio lies in its expansive biochemical dataset. Here's a closer look at what it offers:
Leash Bio's dataset is invaluable for a range of professionals and organizations, including:
Leash Bio is unique because it addresses a critical bottleneck in AI-driven drug discovery: the availability of high-quality, large-scale data. By providing this essential resource, Leash Bio empowers researchers and companies to leverage the full potential of AI to develop life-saving medications more quickly and efficiently. Their focus on generating and curating massive biochemical measurements positions them as a key enabler of the future of drug design.
Combine notes, photos, & bookmarks into stunning AI results.
End to End Web Scraping
Find the unfindable, powered by Exa